Junping Ao
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Obstetrics and Gynecology top 10%
- Pregnancy and preeclampsia studies
Papers in
-
- RNA Interference and Gene Delivery 2
- Circular RNAs in diseases 2
- Advanced biosensing and bioanalysis techniques 2
- Oncology 5
- Co-authors
- Ji Wu (2 shared papers)Xiaoyong Li (1 shared paper)Xiaofei Liang (6 shared papers)Jianren Gu (3 shared papers)Huijuan Zhang (1 shared paper)Weiwei Cheng (1 shared paper)Xinyue Li (1 shared paper)Mingliang Fan (2 shared papers)
- Journals
- Oncotarget (3 papers)Frontiers in Pharmacology (1 paper)Molecular Neurobiology (1 paper)Bioconjugate Chemistry (1 paper)Biomedicine & Pharmacotherapy (1 paper)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Junping Ao
24 papers receiving 718 citations
Peers
Comparison fields: 5 of 86
- Cancer Research 155
- Obstetrics and Gynecology 66
- Biomaterials 92
- Molecular Biology 392
- Pharmaceutical Science 30
Countries citing papers authored by Junping Ao
This map shows the geographic impact of Junping Ao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junping Ao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junping Ao more than expected).
Fields of papers citing papers by Junping Ao
This network shows the impact of papers produced by Junping Ao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junping Ao. The network helps show where Junping Ao may publish in the future.
Co-authors
The 25 scholars most cited alongside Junping Ao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 79 | |
| 2 | 2017 | 76 | |
| 3 | 2015 | 74 | |
| 4 | 2017 | 54 | |
| 5 | 2015 | 50 | |
| 6 | 2018 | 42 | |
| 7 | 2012 | 40 | |
| 8 | 2016 | 40 | |
| 9 | 2014 | 39 | |
| 10 | 2015 | 38 | |
| 11 | 2017 | 33 | |
| 12 | 2015 | 27 | |
| 13 | Silencing of WISP3 suppresses gastric cancer cell proliferation and metastasis and inhibits Wnt/β-catenin signaling. | 2014 | 20 |
| 14 | 2021 | 18 | |
| 15 | 2015 | 16 | |
| 16 | 2018 | 15 | |
| 17 | 2020 | 15 | |
| 18 | 2021 | 13 | |
| 19 | 2016 | 11 | |
| 20 | Dysregulated cell mechanical properties of endometrial stromal cells from endometriosis patients. | 2014 | 10 |
About Junping Ao
Junping Ao is a scholar working on Molecular Biology, Oncology, Cancer Research, Biomedical Engineering and Biomaterials, having authored 25 papers that have together received 725 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (3 papers), Nanoplatforms for cancer theranostics (3 papers), Nanoparticle-Based Drug Delivery (2 papers), RNA Interference and Gene Delivery (2 papers), Circular RNAs in diseases (2 papers), Pain Mechanisms and Treatments (2 papers), Graphene and Nanomaterials Applications (2 papers) and Advanced biosensing and bioanalysis techniques (2 papers). The work is most often cited by research in Cancer Research (155 citations), Obstetrics and Gynecology (66 citations), Biomaterials (92 citations), Molecular Biology (392 citations) and Pharmaceutical Science (30 citations). Junping Ao has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Ji Wu, Xiaoyong Li, Xiaofei Liang, Jianren Gu, Huijuan Zhang, Weiwei Cheng, Xinyue Li, Mingliang Fan, Kai Wang and Bizhi Shi. Their work appears in journals such as Oncotarget, Frontiers in Pharmacology, Molecular Neurobiology, Bioconjugate Chemistry and Biomedicine & Pharmacotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.